Evidence for the efficacy of peginterferon alfa-2a (40 KD) (PEGASYS) in the treatment of HBeAg-positive chronic hepatitis B (CHB) and impact of baseline factors
W.Graham E. Cooksley, Teerha Piratvisuth, Yuan-Jen Wang, Varocha Mahachai, You-Chen Chao, Tawesak Tanwandee, Anuchit Chutaputti, Wen Yu Chang, Friederike E. Zahm, Nigel PluckVolume:
36
Year:
2002
Language:
english
DOI:
10.1016/s0168-8278(02)80017-4
File:
PDF, 165 KB
english, 2002